产品说明书

CLK-IN-T3

Print
Chemical Structure| 2109805-56-1 同义名 : Clk Inhibitor T3
CAS号 : 2109805-56-1
货号 : A353812
分子式 : C28H30N6O2
纯度 : 99%+
分子量 : 482.577
MDL号 : MFCD31689325
存储条件:

粉末 Keep in dark place,Inert atmosphere,Room temperature

液体 -20°C:3-6个月-80°C:12个月

溶解度 :

DMSO: 4 mg/mL(8.29 mM),配合低频超声,并水浴加热至45℃助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方:
生物活性
描述 Cyclin-dependent kinases (CDKs) are a group of multifunctional enzymes consisting of catalytic and regulatory subunits. The regulatory subunit, cyclin, remains dissociated under normal circumstances, and complexation of cyclin with the catalytic subunit of CDK leads to its activation for phosphorylation of protein substrates[2]. CDKs are activated by cyclins, which play important roles in dictating the actions of CDK/cyclin complexes. Cyclin binding influences the substrate specificity of these complexes in addition to their susceptibility to inhibition or degradation. CDK/cyclin complexes are best known to promote cell cycle progression in the mitotic cell cycle but are also crucial for important cellular processes not strictly associated with cellular division[3]. CLK-IN-T3 is a potent inhibitor of CDC-like kinase (CLK) (IC50s: 0.67 nM, 15 nM, and 110 nM for CLK1, CLK2, and CLK3 protein kinases) with anti-cancer activity. CLK-IN-T3 (0.5-1.0 µM; 6 hours) reduces phosphorylation of CLK-targeted SR proteins and CLK proteins increase slightly. CLK-IN-T3 (0.1-10.0 µM; 24 hours) causes mild cell cycle arrest at the G2/M boundary with long-duration (24 h). CLK-IN-T3 has IC50s of 260 nM and 230 nM for DYRK1A and DYRK1B, respectively[4].In embryonic cells, cardiomyocytes, and hearts, the growth and heart rates were significantly slowed in clk-1(-/-) compared with wild-type or heterozygous mouse tissues. Moreover, frequent apoptosis and a significant reduction in mitochondrial functions, including membrane potential and ATP production, were observed in the clk-1(-/-) cells and hearts[5].
实验方案
1mg 5mg 10mg

1 mM

5 mM

10 mM

2.07mL

0.41mL

0.21mL

10.36mL

2.07mL

1.04mL

20.72mL

4.14mL

2.07mL

参考文献

[1]Funnell T, Tasaki S, et al. CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor. Nat Commun. 2017 Dec;8(1):7.

[2]Bharat Goel,et al. Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer. Curr Top Med Chem.2020;20(17):1535-1563.

[3]Nathan Palmer,et al. Less-well known functions of cyclin/CDK complexes. Semin Cell Dev Biol. 2020Nov;107:54-62.

[4] Tyler Funnell,et al. CLK-dependent exon recognition and conjoined gene formation revealed with a novel small molecule inhibitor. Nat Commun. 2017 Feb 23;8(1):7.

[5] Mayumi Takahashi,et al. Reversal of slow growth and heartbeat through the restoration of mitochondrial function in clk-1-deficient mouse embryos by exogenous administration of coenzyme Q10. Exp Gerontol.2012 Jun;47(6):425-31.